ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.00%
US Dollar vs MXN
16.677
0.07%
Brent Oil
82.985
0.17%
Bitcoin
68,228.54
-1.69%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
28/05/202406:37Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:FTAIPFTAI Aviation Ltd
28/05/202406:36PR Newswire (US)Unyted and INU Launch INUVERSE: The Future of Immersive Education
28/05/202406:36Business WireDopavision Announces Topline Results in Clinical Trial of Targeted Photobiomodulation Approach for Progressive Myopia
28/05/202406:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:BNSPFBank Nova Scotia Halifax (PK)
28/05/202406:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APGEApogee Therapeutics Inc
28/05/202406:35GlobeNewswire Inc.Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic DermatitisNYSE:JNJJohnson and Johnson
28/05/202406:34GlobeNewswire Inc.Entourage Health Reports First Quarter 2024 Financial Results: Achieves $16.4 Million in Total Revenue and Marks First EBITDA-Positive QuarterTSXV:ENTGEntourage Health Corp
28/05/202406:33GlobeNewswire Inc.Inter&Co doubles down on SMEs through acquisition of GranitoNASDAQ:INTRInter and Company Inc
28/05/202406:33Business WireT-Mobile to Acquire UScellular Wireless Operations and Deliver Exceptional Value, a Superior 5G Experience and Unparalleled Benefits to Millions of CustomersNASDAQ:TMUST Mobile US Inc
28/05/202406:31IH Market NewsU.S. Futures Present Mixed Pre-Market Performance, Oil Prices SurgeNYSE:OOMAOoma Inc
28/05/202406:30GlobeNewswire Inc.PGS ASA: Calling Notice for 2024 Annual General MeetingTG:PGS1PGS ASA
28/05/202406:30Business WireAffini-T Therapeutics Announces First Patient Dosed in KRAS G12V Phase 1 Program and Presentation of Trial-in-Progress Poster at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
28/05/202406:30GlobeNewswire Inc.Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MDNASDAQ:APGEApogee Therapeutics Inc
28/05/202406:30Business WireDanaos Corporation Reports First Quarter Results for Period Ended March 31, 2024NYSE:DACDanaos Corp
28/05/202406:30GlobeNewswire Inc.TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual MeetingNASDAQ:TGTXTG Therapeutics Inc
28/05/202406:30GlobeNewswire Inc.Venus Concept Announces $35 million Debt-to-Equity Exchange TransactionNASDAQ:VEROVenus Concept Inc
28/05/202406:30Business WireFourKites Signs on as Collaborator to Consortium of Supply Chain Leaders Working to Streamline Scheduling Technology Across the Logistics Industry
28/05/202406:30GlobeNewswire Inc.Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director Nominees on the BLUE Proxy CardNASDAQ:MFINMedallion Financial Corporation
28/05/202406:30GlobeNewswire Inc.Yorbeau Consolidates Interest in Its Beschefer PropertyTSX:YRBYorbeau Resources Inc
28/05/202406:30GlobeNewswire Inc.Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity RequirementNASDAQ:AGFYAgrify Corporation
28/05/202406:30GlobeNewswire Inc.KANZHUN LIMITED repurchased RMB74 million ordinary shares under its repurchase planNASDAQ:BZKanzhun Ltd
28/05/202406:30Business WireAramark to Participate in Upcoming Investor ConferencesNYSE:ARMKAramark
28/05/202406:30Business WireConsensus Cloud Solutions to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference in June 2024NASDAQ:CCSIConcensus Cloud Solutions Inc
28/05/202406:30Business WireCAVA to Participate in Upcoming Investor ConferencesNYSE:CAVACAVA Group Inc
28/05/202406:30Business WireDeepCure Turns Complex Drug Designs into Testable Molecules with Robotic Synthesis Breakthrough
28/05/202406:30GlobeNewswire Inc.Judge Consulting Recognized on 2024 CRN Solution Provider 500 List
28/05/202406:30GlobeNewswire Inc.Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional SharesNASDAQ:DYNDyne Therapeutics Inc
28/05/202406:30Business WireFerrer Obtains the Distribution Rights for Treprostinil Inhalation Solution Including the Potential Indications for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)
28/05/202406:30Business WireEikon Therapeutics Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
28/05/202406:30Business WireJohnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic DermatitisNYSE:JNJJohnson and Johnson

Su Consulta Reciente

LSE
3SVE
Granite 3s Nvda
NASDAQ
PQBW
ASX
CPLN
EU
BER00003T0Z1
Record Bank Record 2.1% ...
LSE
97PB
Mortgage 1 'b'
NASDAQ
ORCI
Opinion Research
COIN
FUMOUST
Alien Milady Fumo
LSE
STPA
ASX
TO2
Toll Holdings - Options Over Bas
LSE
WFCB
LSE
LABL
L&g Gl Brands
USOTC
HUFAF
Hufvudstaden AB (PK)
BITMOT
782397
Netherlands Tf 0,25% Lg2...
BMF
BGIG25
BGIG25 - Fevereiro 2025
USOTC
HAYPF
Hays (PK)
NYSE
DFAW
Dimensional ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados